Sunday, July 14, 2024
    HomeFinanceTreprostinil injection launched in US by Dr Reddy's

    Treprostinil injection launched in US by Dr Reddy’s

    Related stories

    Science Museum scheduled to open by the end of July.

    DEO E Somashekhara Sharma and District Science Officer D...

    Kishan Reddy believes people view BJP as a viable alternative to Congress

    The State BJP executive meeting in Hyderabad on Friday...

    BRS’s Proud Legacy of Advocacy for TG rights

    In Hyderabad, Senior BRS leader V Srinivas Goud expressed...

    Congress leaders blame poor coordination for LS poll defeat

    The PJ Kurien Committee is set to submit a...

    Dr Reddy’s Laboratories Limited, a pharmaceutical company in Hyderabad, has launched Treprostinil Injection in the US market. This medicine is a generic version of Remodulin and has been approved by the US Food and Drug Administration (USFDA). The injection comes in four different vials with varying doses: 20 mg/20 ml, 50 mg/20 ml, 100 mg/20 ml, or 200mg/20 ml.

    Treprostinil injection is used as a prostacyclin mimetic for patients who need to transition from epoprostenol. This medicine helps reduce the rate of clinical deterioration.

    Also read:  Sustainability projects to be launched by the Akshaya Patra Foundation
    - Advertisement -
    Rajesh M
    Rajesh M
    Latest News from Hyderabad, Telangana, India & World!

    Follow us


    Contribute News

    You can contribute an article to Telangana Tribune by dropping a mail at

    Latest stories


    Please enter your comment!
    Please enter your name here